BCAX
Bicara Therapeutics Inc. Common Stock
NASDAQ: BCAX · HEALTHCARE · BIOTECHNOLOGY
$21.58
+1.41% today
Updated 2026-04-30
Market cap
$1.40B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.52
Dividend yield
—
52W range
$8 – $24
Volume
0.6M
Bicara Therapeutics Inc. Common Stock (BCAX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-32.08M | $-45.63M | $-74.75M | $-106.83M |
| Capital expenditures | $192000.00 | $586000.00 | $71000.00 | $280000.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $810000.00 | $1.90M | $7.40M | $15.01M |
| Free cash flow | $-32.27M | $-46.21M | $-74.82M | $-107.11M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |